Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
CAMBRIDGE, Mass., July 27, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology…
Combined company to operate as Ayala Pharmaceuticals, Inc. Merger to add a clinical stage oncology…
SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company…
SEATTLE , July 27, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company…
Phase 1-ready device shows 100% success in human functional study of twelve subjects to date…
Phase 1-ready device shows 100% success in human functional study of twelve subjects to date…
The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of…
The Phase 2 TAHOE study, which is currently enrolling, evaluates the safety and efficacy of…
ASHBURN, Va., July 27, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
ASHBURN, Va., July 27, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., July 27, 2023…
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., July 27, 2023…
NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
NEW YORK and LONDON, July 27, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a…
Preliminary data suggest a chlamydia, gonorrhea and trichomonas (CT/NG/TV) multiplex test is feasible on a…
Dr. Bronstein, the DeepMind Professor of AI at Oxford, will help VantAI unlock the potential…
Dr. Bronstein, the DeepMind Professor of AI at Oxford, will help VantAI unlock the potential…